ArticleLeukemia2022

Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2.

Jing Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.